Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 340-346, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emond, M. J.
Right arrow Articles by Kowdley, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emond, M. J.
Right arrow Articles by Kowdley, K. V.
Related Collections
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1999;45:340-346.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Quantitative Study of the Variability of Hepatic Iron Concentrations

Mary J. Emond1, Mary P. Bronner2, Timothy H. Carlson3, Masami Lin3, Robert F. Labbe3 and Kris V. Kowdley3,4,a

1 Departments of Biostatistics,
2 Pathology,
3 Laboratory Medicine, and
4 Medicine, University of Washington, Seattle, WA 98195.
a Address correspondence to this author at: University of Washington School of Medicine, Box 356174, Seattle WA 98195. Fax 206-598-6706.

Background: The hepatic iron concentration (HIC) is widely used in clinical practice and in research; however, data on the variability of HIC among biopsy sites are limited. One aim of the present study was to determine the variability of HIC within both healthy and cirrhotic livers.

Methods: Using colorimetric methods, we determined HIC in multiple large (microtome) and small (biopsy-sized) paraffin-embedded samples in 11 resected livers with end-stage cirrhosis. HIC was also measured in multiple fresh samples taken within 5 mm of each other ("local" samples) and taken at sites 3–5 cm apart ("remote" samples) from six livers with end-stage cirrhosis and two healthy autopsy livers.

Results: The within-organ SD of HIC was 13–1553 µg/g (CV, 3.6–55%) for microtome samples and 60–2851 µg/g (CV, 15–73%) for biopsy-sized samples. High variability of HIC was associated with mild to moderate iron overload, because the HIC SD increased with increasing mean HIC (P <0.002). Livers with mean HIC >1000 µg/g exhibited significant biological variability in HIC between sites separated by 3–5 cm (remote sites; P <0.05). The SD was larger for biopsy-sized samples than for microtome samples (P = 0.02).

Conclusion: Ideally, multiple hepatic sites would be sampled to obtain a representative mean HIC. © 1999 American Association of Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
 BloodHome page
J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
Blood, August 15, 2005; 106(4): 1460 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. G. St. Pierre, P. R. Clark, W. Chua-anusorn, A. J. Fleming, G. P. Jeffrey, J. K. Olynyk, P. Pootrakul, E. Robins, and R. Lindeman
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
Blood, January 15, 2005; 105(2): 855 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
K. L. Nuttall, J. Palaty, and G. Lockitch
Reference Limits for Copper and Iron in Liver Biopsies
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 443 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L.J. Anderson, S. Holden, B. Davis, E. Prescott, C.C. Charrier, N.H. Bunce, D.N. Firmin, B. Wonke, J. Porter, J.M. Walker, et al.
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Eur. Heart J., December 1, 2001; 22(23): 2171 - 2179.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
G. Crisponi, R. Ambu, F. Cristiani, G. Mancosu, V. M. Nurchi, R. Pinna, and G. Faa
Does Iron Concentration in a Liver Needle Biopsy Accurately Reflect Hepatic Iron Burden in {beta}-Thalassemia?
Clin. Chem., August 1, 2000; 46(8): 1185 - 1188.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.